Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences.

Sci Adv

Department of Biomedical Engineering, McConnell Brain Imaging Centre (BIC), Montreal Neurological Institute (MNI), Faculty of Medicine, School of Computer Science, McGill University, Montreal, Canada.

Published: March 2022

Psychedelics probably alter states of consciousness by disrupting how the higher association cortex governs bottom-up sensory signals. Individual hallucinogenic drugs are usually studied in participants in controlled laboratory settings. Here, we have explored word usage in 6850 free-form testimonials about 27 drugs through the prism of 40 neurotransmitter receptor subtypes, which were then mapped to three-dimensional coordinates in the brain via their gene transcription levels from invasive tissue probes. Despite high interindividual variability, our pattern-learning approach delineated how drug-induced changes of conscious awareness are linked to cortex-wide anatomical distributions of receptor density proxies. Each discovered receptor-experience factor spanned between a higher-level association pole and a sensory input pole, which may relate to the previously reported collapse of hierarchical order among large-scale networks. Coanalyzing many psychoactive molecules and thousands of natural language descriptions of drug experiences, our analytical framework finds the underlying semantic structure and maps it directly to the brain.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926331PMC
http://dx.doi.org/10.1126/sciadv.abl6989DOI Listing

Publication Analysis

Top Keywords

trips neurotransmitters
4
neurotransmitters discovering
4
discovering principled
4
principled patterns
4
patterns 6850
4
6850 hallucinogenic
4
hallucinogenic experiences
4
experiences psychedelics
4
psychedelics alter
4
alter states
4

Similar Publications

Background: A 12-week randomized controlled trial demonstrated that brexpiprazole is efficacious for treating agitation in patients with dementia due to Alzheimer's disease.

Objective: To assess the long-term safety and tolerability of brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease.

Methods: This 12-week, active-treatment (oral brexpiprazole 2 or 3 mg/day) extension trial ran from October 2018-September 2022 at 66 sites in Europe/US.

View Article and Find Full Text PDF

Ketamine modulates the exploratory dynamics and homebase-related behaviors of adult zebrafish.

Pharmacol Biochem Behav

December 2024

Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil; Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria, Santa Maria, RS, Brazil; The International Zebrafish Neuroscience Research Consortium (ZNRC), USA. Electronic address:

Anxiety can be a protective emotion when animals face aversive conditions, but is commonly associated with various neuropsychiatric disorders when pathologically exacerbated. Drug repurposing has emerged as a valuable strategy based on utilizing the existing pharmaceuticals for new therapeutic purposes. Ketamine, traditionally used as an anesthetic, acts as a non-competitive antagonist of the glutamate N-methyl-d-aspartate (NMDA) receptor, and shows potential anxiolytic and antidepressant effects at subanesthetic doses.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines first-time experiences of individuals using LSD, noting a significant surge in recreational use and interest in its therapeutic potential.
  • Data from a 2018 Global Drug Survey, involving 3,340 respondents, highlighted that almost all participants found their experiences exceeded expectations, with most feeling excitement and only a few reporting severe side effects or needing emergency medical treatment.
  • While the overall experiences with LSD were mostly positive, the study emphasizes the need for harm-reduction efforts to ensure user safety as LSD's popularity increases.
View Article and Find Full Text PDF

Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.

Dermatitis

November 2024

Galaria Plastic Surgery & Dermatology, LLC, Chantilly, Virginia, USA.

Article Synopsis
  • The review examines the dermatologic side effects of psychedelic and hallucinogenic substances, which are not well understood despite their therapeutic use.
  • A comprehensive search of medical databases identified 22 studies linking these drugs to various skin reactions in 40 patients.
  • Common skin reactions included hypersensitivity to cannabis, acneiform and urticarial eruptions from MDMA, and various reactions from ketamine and psilocybin, with most cases resolving after stopping the drug.
View Article and Find Full Text PDF

Regulated rapid round trips: Endocytotic cycling of the dopamine transporter shapes motor learning.

J Biol Chem

April 2023

Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria. Electronic address:

The level of dopamine transporters (DATs) in the neuronal plasma membrane shapes learning and motor coordination in mice. Mechanisms underlying the regulated internalization of DAT and its return to the cell surface have been intensively studied in heterologous cells and in neuronal cell bodies. However, whether this cycling also happens in synaptic boutons, or axon terminals, thought to be the major functional site for DAT expression, was an open question that Kearney and colleagues recently addressed in the JBC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!